JILITY Trademark

Trademark Overview


On Wednesday, December 4, 2019, a trademark application was filed for JILITY with the United States Patent and Trademark Office. The USPTO has given the JILITY trademark a serial number of 88714902. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 27, 2021. This trademark is owned by Eli Lilly and Company. The JILITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations in delivery devices, sold as a unit, for the treatment of autoimmune diseases and disorders, bone and skeletal diseases and disorders, diabetes, migraines, neurodegenerative disorders and pain; medical drug delivery devices, sold with pharmaceutical preparations for the treatment of diabetes, migraines, neurodegenerative disorders and pain with pumps for the infusion of the pharmaceutical preparation; medical drug delivery devices in the form of transdermal patches featuring a pharmaceutical preparation for the treatment of migraines, neurodegenerative disorders and pain
jility

General Information


Serial Number88714902
Word MarkJILITY
Filing DateWednesday, December 4, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 27, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 29, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations in delivery devices, sold as a unit, for the treatment of autoimmune diseases and disorders, bone and skeletal diseases and disorders, diabetes, migraines, neurodegenerative disorders and pain; medical drug delivery devices, sold with pharmaceutical preparations for the treatment of diabetes, migraines, neurodegenerative disorders and pain with pumps for the infusion of the pharmaceutical preparation; medical drug delivery devices in the form of transdermal patches featuring a pharmaceutical preparation for the treatment of migraines, neurodegenerative disorders and pain

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 10, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, December 27, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 27, 2021ABANDONMENT - NO USE STATEMENT FILED
Saturday, April 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 15, 2021EXTENSION 1 GRANTED
Thursday, April 15, 2021EXTENSION 1 FILED
Thursday, April 15, 2021TEAS EXTENSION RECEIVED
Tuesday, November 24, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 29, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 29, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 9, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 25, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 25, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, August 25, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 25, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, August 25, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, August 6, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 6, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 6, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 2, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 2, 2020NON-FINAL ACTION E-MAILED
Monday, March 2, 2020NON-FINAL ACTION WRITTEN
Sunday, February 23, 2020ASSIGNED TO EXAMINER
Tuesday, December 10, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 7, 2019NEW APPLICATION ENTERED IN TRAM